| Antiretroviral Therapy for HIV Infection |
1 |
1 |
| HIV Infection |
0 |
0.92 |
| Drug Interaction |
0 |
0.88 |
| Patient Safety |
0 |
0.64 |
| Dietary Supplements |
0 |
0.41 |
| Protease Inhibitor |
0 |
0.29 |
| Dual Protease Inhibitor Regimens |
0 |
0.27 |
| Proteases |
0 |
0.2 |
| Geriatrics |
0 |
0.14 |
| Toxicology |
0 |
0.09 |
| Adverse Effects |
0 |
0.07 |
| Calcium |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Electronic Health Record (EHR) |
0 |
0.07 |
| Electronic Medical Record |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Polypharmacy |
0 |
0.07 |
| Viral Load |
0 |
0.07 |
| Health Care Reform |
0 |
0.04 |
| Osteoarthritis |
0 |
0.04 |